Background: Compared to men, women have lower treatment rates for cardiovascular disease (CVD), are at higher risk for medication non-adherence and have different reasons for being non-adherent. The aim of this study was to synthesize and evaluate gender-specific adherence-promoting interventions for cardiovascular medication and gender-specific effects of gender-neutral interventions. Methods: A systematic literature search was performed in PubMed, Embase, PsycINFO, CINAHL and Cochrane Library from January 2007 to October 2019. Intervention studies (with control group) aimed at improving cardiovascular medication adherence with mini-mally 14 weeks follow-up were included. Two reviewers independently screened titles and abstracts. Full text...
Background: Sex and gender-related factors have been under-investigated as relevant determinants of ...
International audienceDespite the availability of efficient therapies to reduce the risk of cardiova...
Cardiovascular disease (CVD) represents the leading cause of death worldwide, and equally affects bo...
Background: Compared to men, women have lower treatment rates for cardiovascular disease (CVD), are ...
Background Compared to men, women have lower treatment rates for cardiovascular disease (CVD), are a...
Introduction: Pharmacological treatment is an important component of secondary prevention in acute c...
Women and men are different. This may seem obvious, but cardiovascular research too often treats wom...
Statins are a main curbstone in the prevention of cardiovascular disease (CVD), pandemic in 21st cen...
Introduction Cardiovascular disease (CVD) is a leading cause of death and disability as well as a ma...
Background: In the last decades aging of population is becoming even more prevalent, with consequent...
Abstract Background: Adherence to treatment is a cornerstone regarding progression of coronary hear...
The interest of the scientific and medical community on the impact of cardiovascular diseases in wom...
Background Sex differences in the management of cardiovascular disease have been reported in seconda...
BACKGROUND:Women are less likely to be prescribed statins than men. Existing reports explain only a ...
Women are less likely to be prescribed statins than men. Existing reports explain only a fraction of...
Background: Sex and gender-related factors have been under-investigated as relevant determinants of ...
International audienceDespite the availability of efficient therapies to reduce the risk of cardiova...
Cardiovascular disease (CVD) represents the leading cause of death worldwide, and equally affects bo...
Background: Compared to men, women have lower treatment rates for cardiovascular disease (CVD), are ...
Background Compared to men, women have lower treatment rates for cardiovascular disease (CVD), are a...
Introduction: Pharmacological treatment is an important component of secondary prevention in acute c...
Women and men are different. This may seem obvious, but cardiovascular research too often treats wom...
Statins are a main curbstone in the prevention of cardiovascular disease (CVD), pandemic in 21st cen...
Introduction Cardiovascular disease (CVD) is a leading cause of death and disability as well as a ma...
Background: In the last decades aging of population is becoming even more prevalent, with consequent...
Abstract Background: Adherence to treatment is a cornerstone regarding progression of coronary hear...
The interest of the scientific and medical community on the impact of cardiovascular diseases in wom...
Background Sex differences in the management of cardiovascular disease have been reported in seconda...
BACKGROUND:Women are less likely to be prescribed statins than men. Existing reports explain only a ...
Women are less likely to be prescribed statins than men. Existing reports explain only a fraction of...
Background: Sex and gender-related factors have been under-investigated as relevant determinants of ...
International audienceDespite the availability of efficient therapies to reduce the risk of cardiova...
Cardiovascular disease (CVD) represents the leading cause of death worldwide, and equally affects bo...